Scotiabank analyst Robert Hope raised the firm’s price target on Boralex (BRLXF) to C$37.25 from C$31 and keeps a Sector Perform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRLXF:
- Boralex downgraded to Sell from Buy at TD Securities
- Boralex to Go Private in $9 Billion Brookfield–La Caisse Deal to Accelerate Growth
- Boralex to be acquired by Brookfield and La Caisse for C$37.25 in cash per share
- Boralex confirms special committee formed to review alternatives
- Boralex Confirms Strategic Review While Reaffirming Core Renewable Strategy